Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: Eur J Cancer. 2009 Jul 15;45(18):3271–3281. doi: 10.1016/j.ejca.2009.06.011

Table 4.

Meta-analysis of current and published data on risk of melanoma.

SNP Number
of
studies		 Reference Heterozygotes Homozygotes Heterozygotes
and homozygotes
Pooled OR (95% CI) [I2] Pooled OR (95% CI) [I2] Pooled OR (95% CI) [I2]
Cdx-2 3 GG 0.95 (0.81, 1.12) [0%] 1.00 (0.69, 1.46) [0%] 0.96 (0.82, 1.12) [0%]
GATA 5 AA 1.09 (0.88, 1.35) [0%] 0.92 (0.62, 1.36) [63%] 1.06 (0.86, 1.30) [44%]
FokI 7 CC (FF) 1.20 (1.06, 1.35) [0%] 1.21 (0.94, 1.57) [50%] 1.19 (1.05, 1.35) [18%]
BsmI 5 GG (bb) 0.82 (0.72, 0.93) [0%] 0.79 (0.66, 0.95) [42%] 0.81 (0.72, 0.92) [0%]
TaqI 5 TT (TT) 0.96 (0.75, 1.22) [65%] 0.91 (0.69, 1.20) [46%] 0.95 (0.75, 1.20) [69%]